Agreed, The last thing they want is another SPP. We’ll never see...

First 106 Last

Share
Profile

Follow
Taureanbull

3,022 Posts.

6482

14/04/24

16:51

Post #: 73337864
Share

Originally posted by Shaunbra ↑

Completely agree Rainman. There are 158m D’s listed worth over $70m to Imugene. That’s significant cash for any company. If we are sitting on the real deal, as many (including myself) believe we are, then there are 70 million reasons for IMU to announce information to the market to get the Ds in the money. This could be in the way of spectacular data or it could be commercial in nature - either way, the company undoubtedly has a looming date (31 Aug 2024) in the back of their mind.

I speculate that the latest MAST data cut to December 2023 is potentially an intentional decision by Imugene / trial organisers as they allow time for efficacious effects of CF33 Vaxinia to take hold. I wonder if rather than drip-feeding positive news, they are amassing compelling data for a more significant announcement. Something big to surely get the Ds across the line.

GLTAH, dyor.

Expand

Agreed, The last thing they want is another SPP. We’ll never see another one of those. As both LC and NE have said they are in regular contact with interested US parties.

So saving the data till June/july and dropping a real bomb would do it. And fall back is a US raise by JPM, after the data to get price up substantially.

They rewarded shareholders big time last SPP and all they copped was grief from some quarters . I just can’t ever see them giving those people another lick.

IMU Price at posting: 9.2¢ Sentiment: Buy Disclosure: Held
16 Upvote

0 Great analysis

Reply